Coopting T cell proximal signaling molecules enables Boolean logic-gated CAR T cell control
Aidan M. TousleyiD, Maria Caterina RotirotiiD, Louai LabaniehiD, Lea Wenting RysavyiD, Skyler P. RietbergiD, Eva L. de la SernaiD, Guillermo Nicolás DaltoniD, Dorota Danuta KlysziD, Evan W. WeberiD, Won‐Ju KimiD, Peng XuiD, Elena SotilloiD, Alexander R. DunniD, Crystal Lee MackalliD, Robbie G. MajzneriD
Abstract
Introductory paragraphWhile CAR T cells have altered the treatment landscape for B cell malignancies, the risk of on-target, off-tumor toxicity has hampered their development for solid tumors because most target antigens are shared with normal cells1,2. Researchers have attempted to apply Boolean logic gating to CAR T cells to prevent on-target, off-tumor toxicity3-7; however, a truly safe and effective logic-gated CAR has remained elusive8. Here, we describe a novel approach to CAR engineering in which we replace traditional ITAM-containing CD3{zeta} domains with intracellular proximal T cell signaling molecules. We demonstrate that certain proximal signaling CARs, such as a ZAP-70 CAR, can activate T cells and eradicate tumors in vivo while bypassing upstream signaling proteins such as CD3{zeta}. The primary role of ZAP-70 is to phosphorylate LAT and SLP-76, which form a scaffold for the propagation of T cell signaling. We leveraged the cooperative role of LAT and SLP-76 to engineer Logic-gated Intracellular NetworK (LINK) CAR, a rapid and reversible Boolean-logic AND-gated CAR T cell platform that outperforms other systems in both efficacy and the prevention of on-target, off-tumor toxicity. LINK CAR will dramatically expand the number and types of molecules that can be targeted with CAR T cells, enabling the deployment of these powerful therapeutics for solid tumors and diverse diseases such as autoimmunity9 and fibrosis10. In addition, this work demonstrates that the internal signaling machinery of cells can be repurposed into surface receptors, a finding that could have broad implications for new avenues of cellular engineering.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Generation of anti-tumor chimeric antigen receptors incorporating T cell signaling motifs
L. Balagopalan, T. Moreno, … L. E. Samelson·bioRxiv·Dec 25, 2022
- CAR T cell cytotoxic responses are rapidly generated and sensitive to the unligated TCR
Kevin L. Scrudders, Suriya Selvarajan, … Shalini T. Low-Nam·bioRxiv·Jul 25, 2025
- Balancing activation and costimulation of CAR tunes signaling dynamics and enhances therapeutic potency
J. Sun, Y. Duan, … M. Sadelain·bioRxiv·Mar 1, 2022
- Inefficient ZAP70-Signaling Blunts Antigen Detection by CAR-T-Cells
V. Gudipati, J. Rydzek, … J. B. Huppa·bioRxiv·Jul 30, 2019
- Solid tumor CAR T cells engineered with fusion proteins targeting PDL1 for localized IL-12 delivery
John Paul Murad, Lea Christian, … Saul J. Priceman·bioRxiv·Apr 4, 2025
- Engineering clinically-approved drug gated CAR circuits
Hui-Shan Li, Nicole M. L. Wong, … Wilson W. Wong·Cancer CellPeer-reviewed·Sep 8, 2022